Company Overview and News

 
Asian firms' confidence sinks to near three-year low on trade war fears, survey shows

5h malaymail
JAKARTA, Sept 19 — Confidence among Asian companies slumped to the weakest in almost three years in the third quarter as businesses feared blowback from a worsening global trade war, a Thomson Reuters/Insead survey showed.
OISHF 500325 OISHY RELIANCE RIGD 7269 TRI RLNIY DLELY OSH

 
Asian firms#39; confidence sinks to near three-year low on trade war fears: Thomson Reuters/INSEAD survey

5h moneycontrol
Confidence among Asian companies slumped to the weakest in almost three years in the third quarter as businesses feared blowback from a worsening global trade war, a Thomson Reuters/INSEAD survey showed.
OISHF 500325 OISHY RELIANCE RIGD 7269 TRI RLNIY DLELY OSH

 
Asian firms' confidence sinks to near three-year low on trade war fears: Thomson Reuters/INSEAD poll

6h reuters
JAKARTA (Reuters) - Confidence among Asian companies slumped to the weakest in almost three years in the third quarter as businesses feared blowback from a worsening global trade war, a Thomson Reuters/INSEAD survey showed.
OISHF 500325 OISHY RELIANCE RIGD 7269 RLNIY DLELY OSH

 
Asian firms' confidence sinks to near three-year low on trade war fears: Thomson Reuters/INSEAD

6h theedgemarkets
JAKARTA (Sep 19): Confidence among Asian companies slumped to the weakest in almost three years in the third quarter as businesses feared blowback from a worsening global trade war, a Thomson Reuters/INSEAD survey showed.
OISHF 500325 OISHY RELIANCE RIGD 7269 TRI RLNIY DLELY OSH

 
Asian firms' confidence sinks to near three-year low on trade war fears: Thomson Reuters/INSEAD

6h reuters
JAKARTA (Reuters) - Confidence among Asian companies slumped to the weakest in almost three years in the third quarter as businesses feared blowback from a worsening global trade war, a Thomson Reuters/INSEAD survey showed.
OISHF 500325 OISHY RELIANCE RIGD 7269 RLNIY DLELY OSH

 
Oil Search (OISHY) Presents At 25th CLSA Investors' Forum - Slideshow

2018-09-11 seekingalpha
The following slide deck was published by Oil Search Ltd. ADR in conjunction with this event.
OISHF OISHY OSH

 
ASX snaps eight-session losing streak as banks advance

2018-09-11 theage.com.au
Australian shares snapped an eight-session losing streak on Tuesday as banks and Telstra, along with a handful of miners, helped the market take back some losses made amid ongoing Sino-US trade tensions and turmoil in emerging markets.
2282 DB OISHY NAB NASXF MCHVF NABZY WHC OGFGY OISHF NAUBF MCHVY ARLUF ALL OGFGF ORG OSH

 
ASX snaps eight-session losing streak as banks advance

2018-09-11 smh.com.au
Australian shares snapped an eight-session losing streak on Tuesday as banks and Telstra, along with a handful of miners, helped the market take back some losses made amid ongoing Sino-US trade tensions and turmoil in emerging markets.
2282 DB OISHY NAB NASXF MCHVF NABZY WHC OGFGY OISHF NAUBF MCHVY ARLUF ALL OGFGF ORG OSH

2
Markets Live: ASX closes at lowest value since June

2018-09-10 theage.com.au
Below is William's market wrap. I will be back editing tomorrow. CSL is going ex-dividend tomorrow by 127.8 cents, and NAB's business conditions indicator will be out in the morning.
BGCHY RIO BLT RIO MAYNF OGFGY OISHF BEPTF RTPPF MYX RTNTF INCZY OSH PRY OISHY BHPBF BGA WTCHF BCHEY MYPHY PHCRY BPT PTM BHP RIO BBL PHCRF BHP OGFGF BHPLF ICPVF IPL ORG

2
Markets Live: ASX closes at lowest value since June

2018-09-10 smh.com.au
Below is William's market wrap. I will be back editing tomorrow. CSL is going ex-dividend tomorrow by 127.8 cents, and NAB's business conditions indicator will be out in the morning.
BGCHY RIO BLT RIO MAYNF OGFGY OISHF BEPTF RTPPF MYX RTNTF INCZY OSH PRY OISHY BHPBF BGA WTCHF BCHEY MYPHY PHCRY BPT PTM BHP RIO BBL PHCRF BHP OGFGF BHPLF ICPVF IPL ORG

 
'Lip service': Call for investors to step up action on climate risk

2018-09-04 theage.com.au
Investors have been urged to “step up the pressure” on companies to act on climate change as annual meeting season approaches, with a report arguing corporate Australia is paying lip-service to the issue.
OISHF ASXFF OISHY ASXFY WHC OSH

 
'Lip service': Call for investors to step up action on climate risk

2018-09-04 smh.com.au
Investors have been urged to “step up the pressure” on companies to act on climate change as annual meeting season approaches, with a report arguing corporate Australia is paying lip-service to the issue.
OISHF ASXFF OISHY ASXFY WHC OSH

 
How climate policy wars are frustrating corporate Australia

2018-08-29 theedgemarkets
SYDNEY (Aug 29): Australia’s revolving door of political leadership has hit confidence in sectors particularly prone to policy uncertainty, such as energy, which could hurt business investment and push back the timeframe for a central bank interest rate hike.
OISHF OISHY OSH

 
How climate policy wars are frustrating corporate Australia

2018-08-29 channelnewsasia
SYDNEY: Australia's revolving door of political leadership has hit confidence in sectors particularly prone to policy uncertainty, such as energy, which could hurt business investment and push back the timeframe for a central bank interest rate hike.
OISHF OISHY OSH

 
Will China Impose Tariffs On U.S. LNG?

2018-08-23 oilprice
I'm an oil markets analyst, journalist and author that has been working out of the Asia-Pacific region for 12 years. I’ve covered oil, energy markets…
OISHF WOPEF OISHY WPL WOPEY OSH

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:OSH / OIL SEARCH LIMITED on message board site Silicon Investor.

Technical Analysis for Macintosh Users Technical Analysis for Macintosh Users Technical Analysis for Macintosh Users Radioshack Corp. Radioshack Corp. Radioshack Corp.
Joshua Gold Resources (JSHG) Joshua Gold Resources (JSHG) Joshua Gold Resources (JSHG) Macintosh Support Group Macintosh Support Group Macintosh Support Group
Toshiba out of running for Elphida Toshiba out of running for Elphida Toshiba out of running for Elphida Oshkosh Truck Corporation Oshkosh Truck Corporation Oshkosh Truck Corporation
MOSH ... Bargain Oil Penny MOSH ... Bargain Oil Penny MOSH ... Bargain Oil Penny Toshiba TOSBF Toshiba TOSBF Toshiba TOSBF
Bioshield Tech Bioshield Tech Bioshield Tech RSH: Radioshack Corp. RSH: Radioshack Corp. RSH: Radioshack Corp.